Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 19, 2019
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
Filling in the gap on prevalence of viral infections
From the Ramsey Group, Public Health Sciences Division
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
Cancer Research in 2019: Why we are counting on data science and tech to defeat cancer
Why we are counting on data science and tech to defeat cancer
7 lung cancer misconceptions
Myths and misinformation still keep many people in the dark – and that’s bad news for their health
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
Fred Hutch, Microsoft partner to improve cancer care delivery
Project to flag treatment-related symptoms early is revealed at Seattle conference
Hutch health economics releases first public report on cancer care quality and cost
Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration
Finasteride can reduce prostate cancer risk long term
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Counting cancer cures when calculating QALYs
From the Othus and Ramsey Labs, Public Health Sciences Division.
A model for progress in lung cancer survival
From the Roth and Ramsey Labs, Public Health Sciences Division
Surviving cancer without going broke
HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Collaborating to boost value-based care
HICOR hammers out solutions, addresses hard questions on cost and cancer care at third annual summit
Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology
Celebrating faculty and staff achievements
Commentary: Oncologist speaks out on human toll of high health care costs
A Fred Hutch researcher speaks out on the human cost of the ‘unfettered, unbridled greed’ within our health care system
Cancer, bankruptcy and death: study finds a link
A new Fred Hutch study finds that the 3 percent of cancer patients who go bankrupt are much more likely to die
Another health disparity: clinical trials
Low-income cancer patients are less likely to take part in clinical trials for new treatments, study shows
Nation's top oncologists take aim at sky-high drug costs
Cancer patients praise scathing report; experts from Fred Hutch, other top treatment centers decry cancer care's financial burden
Medicare to reimburse for end-of-life conversations
Medicare to reimburse for end-of-life conversations between doctors and patients
Cruel choices: Buy lifesaving meds or groceries?
Cancer patients are often ‘collateral damage’ of drug-pricing war